It is believed that DNMT3A mutations arise in hematopoietic progenitor stem cells, upstream of T-cell lineage commitment based on the observation of identical DNMT3A and TET2 mutations in tumor and normal cells in T-cell lymphoma patients [61]. Here, TET2 is linked to neoplasm.